ccording to the latest report by IMARC Group, titled Fractional Flow Reserve Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global fractional flow reserve market is expected to exhibit a CAGR of 12.1% during 2022-2027

Fractional flow reserve (FFR) is a guide wire-based procedure assisting in the measurement of blood pressure and flows through an isolated segment of a coronary artery. It is utilized in the assessment of intermediate blockages, which determines the need for stenting or angioplasty. As FFR is cost-effective and helps in avoiding unnecessary surgeries, it is gaining traction around the world.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Fractional Flow Reserve Market Trends:

A considerable rise in the prevalence of cardiovascular diseases (CVDs) like hypertension and coronary artery diseases represents one of the major factors propelling the growth of the market. Apart from this, due to sedentary lifestyles and increasing consumption of fast food, there is a significant increase in the occurrences of chronic diseases, including type II diabetes. As these diseases cause blockages, strokes, or heart attacks, the demand for FFR is catalyzing across the globe. Furthermore, the key players are investing in research and development (R&D) activities, which is creating a favorable market outlook.

Global Fractional Flow Reserve Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, ACIST Medical Systems Inc. (Bracco S.p.A.), Boston Scientific Corporation, CathWorks Ltd., Heartflow Inc., Koninklijke Philips N.V., Medis Medical Imaging Systems B.V., Opsens Inc. , Pie Medical Imaging B.V. (Esaote Group), Siemens Healthineers AG and Terumo Medical Corporation.

The report has segmented the market on the basis on region, product, application and end user.

Breakup by Product:

  • FFR Guidewires
  • FFR Monitoring Systems

Breakup by Application:

  • Multi-Vessel Coronary Artery Disease
  • Single-Vessel Coronary Artery Disease

Breakup by End User:

  • Hospitals and Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/3oVqOmE

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800